Why the study?
Optimal intraoperative fluid management in liver surgery has not been established.
Does very restrictive intraoperative fluid management reduce postoperative morbidity in patients undergoing liver resection?
Does very restrictive intraoperative fluid management reduce postoperative morbidity in patients undergoing liver resection?
In liver resection, very restrictive fluid management does not improve overall morbidity and may be associated with longer hospital stays and higher in-hospital mortality compared to normal fluid management.
This is the authors' abstract. We don't add key points for this paper.
As optimal intraoperative fluid management in liver surgery has not been established, we retrospectively analyzed our fluid strategy in a high-volume liver surgery center in 666 liver resections. Intraoperative fluid management was divided into very restrictive (<10 m kg−1 h−1) and normal (≥10 mL kg−1 h−1) groups for study group characterization. The primary endpoint was morbidity as assessed by the Clavien–Dindo (CD) score and the comprehensive complication index (CCI). Logistic regression models identified factors most predictive of postoperative morbidity. No association was found between postoperative morbidity and fluid management in the overall study population (p = 0.89). However, the normal fluid management group had shorter postoperative hospital stays (p = <0.001), shorter ICU stays (p = 0.035), and lower in-hospital mortality (p = 0.02). Elevated lactate levels (p < 0.001), duration (p < 0.001), and extent of surgery (p < 0.001) were the most predictive factors for postoperative morbidity. In the subgroup of major/extreme liver resection, very low total (p = 0.028) and normalized fluid balance (p = 0.025) (NFB) were associated with morbidity. Moreover, fluid management was not associated with morbidity in patients with normal lactate levels (<2.5 mmol/L). In conclusion, fluid management in liver surgery is multifaceted and must be applied judiciously as a therapeutic measure. While a restrictive strategy appears attractive, hypovolemia should be avoided.
Answers are grounded in this paper and cite their sources.
No morbidity difference by fluid strategy in this cohort; leaves open optimal approach pending randomized trials.
No takes yet. Share an insight, caveat, or question.
Hoeter et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: